| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054625 | Oral Oncology | 2016 | 8 Pages |
Abstract
Our long-term results suggested better outcomes in LAHNSCC patients receiving concurrent cisplatin over cetuximab regardless of HPV/p16 status.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Dan Ou, Antonin Levy, Pierre Blanchard, France Nguyen, Ingrid Garberis, Odile Casiraghi, Jean-Yves Scoazec, François Janot, Stephane Temam, Eric Deutsch, Yungan Tao,